Receptos Reports First Quarter 2014 Financial Results

[GlobeNewswire] – – Top-line results of Phase 2 trial of RPC1063 in relapsing multiple sclerosis expected in mid-2014 – – Phase 3 trial of RPC1063 in relapsing multiple sclerosis enrolling patients globally – – Results … more

View todays social media effects on RCPT

View the latest stocks trending across Twitter. Click to view dashboard

See who Receptos is hiring next, click here to view